Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Should Investors Take A Chance On Savient?
Should Investors Take A Chance On Savient?
Should Investors Take A Chance On Savient?
Submitted by
admin
on October 26, 2010 - 11:50am
Source:
Investopedia
News Tags:
Savient
Krystexxa
Bristol-Myers Squibb
Forest Labs
Merck
Novartis
PDI Pharma
Pfizer
Headline:
Should Investors Take A Chance On Savient?
Do Not Allow Advertisers to Use My Personal information